Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Drug Discovery Technologies|March 13, 2020
Structural And Computational Perspectives of Selectively Targeting Mutant ProteinsMathew A Coban, Sarah Fraga, Thomas R CaulfieldThe FEBS Journal|November 28, 2025
Therapeutic potential of inhibitors of gelatinases MMP-2 and MMP-9 for the treatment of breast cancerAlireza Shoari, Mathew A Coban, Evette S RadiskyCancers|January 28, 2026
Matrix Metalloproteinases in Hepatocellular Carcinoma: Mechanistic Roles and Emerging Inhibitory Strategies for Therapeutic InterventionAlexandra M Dimesa, Mathew A Coban, Alireza ShoariFrontiers in Molecular Biosciences|December 11, 2023
Structure and computation-guided yeast surface display for the evolution of TIMP-based matrix metalloproteinase inhibitorsAlireza Shoari, Ghazaleh Khalili-Tanha, Mathew A Coban, et al.Biomolecules|January 25, 2025
Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer TherapyAlireza Shoari, Arghavan Ashja Ardalan, Alexandra M Dimesa, et al.Biomolecules|September 16, 2020
Structural Models for the Dynamic Effects of Loss-of-Function Variants in the Human SIM1 Protein Transcriptional Activation DomainMathew A Coban, Patrick R Blackburn, Murray L Whitelaw, et al.The Journal of Biological Chemistry|May 23, 2025
Directed evolution of metalloproteinase inhibitor TIMP-1 for selective inhibition of MMP-9 exploits catalytic and fibronectin domain interactionsAlireza Shoari, Mathew A Coban, Alexandra Hockla, et al.Communications Biology|July 7, 2025
Dynamicasome-a molecular dynamics-guided and AI-driven pathogenicity prediction catalogue for all genetic mutationsNaeyma N Islam, Mathew A Coban, Jessica M Fuller, et al.Genes|October 28, 2023
Statistical Mechanics Metrics in Pairing and Parsing In Silico and Phenotypic Data of a Novel Genetic NFκB1 (c.T638A) VariantEman N Chaudhri, Jessica M Abbott, Naeyma N Islam, et al.Biomolecules|June 2, 2021
Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target EngagementMathew A Coban, Juliet Morrison, Sushila Maharjan, et al.Pageof 2